World's Best Scientists 2026 revealed!
Christian Wiesmann

Christian Wiesmann

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
18506
World Ranking
11156
National Ranking
199

Overview

Christian Wiesmann is affiliated with Novartis in Switzerland. Their research spans multiple areas within medicine, biochemistry, genetics, and molecular biology.

Their work covers various subfields, including molecular biology, immunology, public health, environmental and occupational health, cardiology and cardiovascular medicine, and epidemiology. Wiesmann's research topics address Trypanosoma species and related implications, biochemical and molecular research, the complement system in diseases, retinal diseases and treatments, anesthesia and pain management, pregnancy-related medical research, and cardiovascular issues in pregnancy.

Wiesmann has contributed notably to several publications, with a concentration in the Journal of Medicinal Chemistry, where three papers have appeared. Other publication venues include Advanced Therapeutics, ACS Medicinal Chemistry Letters, Nature Chemical Biology, and PubMed.

Key recent papers authored or co-authored by Wiesmann include:

  • Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases (2020, Journal of Medicinal Chemistry)
  • Discovery of 4-((2 S,4 S )-4-Ethoxy-1-((5-methoxy-7-methyl-1 H -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases (2020, Journal of Medicinal Chemistry)
  • BindingDB Entry 50010578: Discovery of 4-((2 (2021, PubMed)
  • Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT) (2022, Journal of Medicinal Chemistry)
  • Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors (2020, ACS Medicinal Chemistry Letters)

Frequent co-authors in Wiesmann's research include:

  • C. Be
  • Rajeshri G. Karki
  • P. Erbel
  • Toshio Kawanami
  • Frédéric Cumin

Best Publications

  • De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

    Ingrid E. Wertz;Karen M. O'Rourke;Honglin Zhou;Michael Eby

  • Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.

    Y. Chen;C. Wiesmann;G. Fuh;Bing Li

  • The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†

    Adrian J. Folkes;Khatereh Ahmadi;Wendy K. Alderton;Sonia Alix

  • Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor

    Christian Wiesmann;Germaine Fuh;Hans W. Christinger;Charles Eigenbrot

  • Allosteric inhibition of protein tyrosine phosphatase 1B.

    Christian Wiesmann;Kenneth J Barr;Jenny Kung;Jiang Zhu

  • Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor

    C Wiesmann;M.H Ultsch;S.H Bass;A.M. de Vos

  • The discovery of first-in-class drugs: origins and evolution.

    Joerg Eder;Richard Sedrani;Christian Wiesmann

  • Anti-vegf antibodies

    Germaine Fuh;Hans-Peter Gerber;Wei-Ching Liang;Frederic A. Fellouse

  • Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site

    Jenny Bostrom;Shang-Fan Yu;David Kan;Brent A. Appleton

  • High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.

    Frederic A. Fellouse;Kaori Esaki;Sara Birtalan;Demetrios Raptis

  • Cryo-EM in drug discovery: achievements, limitations and prospects

    Jean-Paul Renaud;Ashwin Chari;Claudio Ciferri;Wen-Ti Liu

  • Synthetic antibodies from a four-amino-acid code: A dominant role for tyrosine in antigen recognition

    Frederic A. Fellouse;Christian Wiesmann;Sachdev S. Sidhu

  • Macrophage complement receptors and pathogen clearance

    Menno van Lookeren Campagne;Christian Wiesmann;Eric J Brown

  • Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers

    Georgia Hatzivassiliou;Jacob R. Haling;Huifen Chen;Kyung Song

  • Crystal structure of the HGF β‐chain in complex with the Sema domain of the Met receptor

    Jennifer Stamos;Robert A Lazarus;Xiaoyi Yao;Daniel Kirchhofer

  • Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice

    Jing Qing;Xiangnan Du;Yongmei Chen;Pamela Chan

  • Nerve growth factor: structure and function.

    C Wiesmann;A M de Vos

  • Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer

    Daniel P. Sutherlin;Linda Bao;Megan Berry;Georgette Castanedo

  • Structure of C3b in complex with CRIg gives insights into regulation of complement activation

    Christian Wiesmann;Kenneth J. Katschke;JianPing Yin;Karim Y. Helmy

  • Comprehensive Analysis of the Factors Contributing to the Stability and Solubility of Autonomous Human VH Domains

    Pierre A. Barthelemy;Helga Raab;Brent A. Appleton;Christopher J. Bond

Frequent Co-Authors

Sachdev S. Sidhu
Sachdev S. Sidhu University of Waterloo
Menno van Lookeren Campagne
Menno van Lookeren Campagne Amgen (United States)
Germaine Fuh
Germaine Fuh Genentech
Mark Ultsch
Mark Ultsch Genentech
Hans-Peter Gerber
Hans-Peter Gerber Seattle Genetics (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Christian Wiesmann

Trending Scientists

Recently Published Articles